Fig. 2
From: Statin use and risk of HCC in patients with MASLD and T2DM: an umbrella review and meta-analysis
Meta-analysis of the association between statin use and HCC risk in patients with a. T2DM or MASLD, b. T2DM, and c. MASLD studies
Fig. 2 | BMC Cancer